| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |